Ramy Tadros compensation by year
MetLife Summary Compensation Table · all 3 fiscal years held| Component | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Salary | $876,250 | $907,500 | $941,250 |
| Bonus | $0 | $0 | $0 |
| Stock awards | $3,643,454 | $3,338,083 | $4,365,808 |
| Option awards | $451,678 | $481,576 | $0 |
| Non-equity incentive | $2,200,000 | $2,100,000 | $2,100,000 |
| Pension and deferred compensation | $360,686 | $230,028 | $393,642 |
| All other | $127,050 | $124,300 | $121,650 |
| Total | $7,659,118 | $7,181,487 | $7,922,350 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: MetLife Inc DEF 14A filed April 29, 2026, accession 0001099219-26-000026, and prior-year filings. Open the filing on EDGAR.
Equity holdings
unvested awards at FY2025 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| PSU | 147,307 | $11,628,415 | — |
| RSU | 34,335 | $2,710,405 | — |
| Option | 8,574 | — | $71.73 |
| Option | 18,742 | — | $69.16 |
Per the Outstanding Equity Awards at Fiscal Year-End table in MetLife Inc's FY2025 proxy; value at the fiscal year-end close, as the company printed it.
Insider transactions since the last proxy
3 Form 4 lines since the FY2025 proxy (filed April 29, 2026)current to 2026-09-24 · updated nightly
| Date | Transaction | Plan | Shares | Price | Held after |
|---|---|---|---|---|---|
| 2026-09-08 | Grant or award | — | 115 | $95.50 | 212,695 |
| 2026-08-31 | Tax withholding | — | 4,366 | $95.17 | 212,580 |
| 2026-06-09 | Grant or award | — | 127 | $85.57 | 216,946 |
The 3 most recent of 3 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →
Change-in-control & termination
estimated payments MetLife discloses, by trigger · FY2024| Trigger | Cash severance | Accelerated equity | Benefits continuation | Total as disclosed |
|---|---|---|---|---|
| Death | $0 | $9,608,610 | $0 | $9,608,610 |
| Voluntary resignation | $0 | $0 | $0 | $0 |
| Change in control, no termination | $0 | $9,608,610 | $0 | $9,608,610 |
| Involuntary termination without cause | $615,865 | $3,157,400 | $0 | $3,776,336 |
| Change in control and involuntary termination | $6,296,667 | $9,608,610 | $89,221 | $15,994,498 |
Per the Potential Payments Upon Termination or Change in Control table in MetLife Inc's FY2024 proxy. Estimates as the company printed them; a dash means it printed no figure.
MetLife’s named executive officers, FY2025
as the company reported each| Named executive officer | Role | FY2025 total |
|---|---|---|
| Michel Khalaf | President and Chief Executive Officer | $22,364,273 |
| John McCallion | EVP, CFO of MetLife, Inc., and Head of MIM | $9,417,412 |
| Ramy Tadros · this page | Regional President, U.S. Business, and Head of MLH | $7,922,350 |
| Bill Pappas | EVP and Head of Global Technology and Operations | $7,919,406 |
| Marlene Debel | EVP, Chief Risk Officer of MetLife, Inc., and Head of MII | $6,593,728 |
The full MetLife compensation record
free company briefThis page is one person within MetLife's record. The company brief lists every named executive, each linking to their own page.
Compensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order MetLife's full Executive Compensation Report with peer benchmarking.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are MetLife's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.
Velarion Pro: every company page, peer tools and exports, one seat